Grant supports gene-editing research for rare metabolic diseases

A $14M grant will fund research on gene-editing therapies for rare metabolic diseases at the Perelman School of Medicine at the University of Pennsylvania (Penn) and Children’s Hospital of Philadelphia (CHOP).

What Florida’s new 6-week abortion ban means for the South, and traveling patients

Monica Kelly was thrilled to learn she was expecting her second child.

April 29, 2024

In ‘major milestone,’ FDA approves first cell therapy for solid tumors

Nearly four decades after its first conception, the first TIL therapy, an immunotherapy that harvests cancer-fighting immune cells from the patient’s own body, received accelerated

February 17, 2024

Cyltezo Pen: first interchangeable biosimilar to Humira rolls out across US – Pharmaceutical Technology

Boehringer Ingelheim has launched its Cyltezo Pen in what will be a landmark year for Humira biosimilar launches. Image credit: Shutterstock/Michael Vi Boehringer Ingelheim’s new

July 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.